Several alterations can contribute to gliomagenesis, including isocitrate dehydrogenase mutation (IDH-1), alpha-thalassemia/mental retardation, X-linked mutation (ATRX), and tumor protein p53 mutation (TP53). This evidence concerns the gene IDH3A and alpha thalassemia spectrum.